Key areas of focus include: Metabolic: appetite regulation, energy balance, glucose metabolism
In the study published by the Jama Network (linked above), it was found that individuals who use GLP-1 drugs have a 9.09 times higher risk of developing pancreatitis
They are essential for maintaining functional strength and mobility during weight loss
Your medical history, the reason for your cholecystectomy, any ongoing digestive symptoms, and your overall health status all influence whether these medications represent an appropriate treatment option
Some studies suggest these drugs might help control inflammation and cell growth in ways that could be beneficial
"Broader access to these medicines is critical, which is why Lilly is committed to working with healthcare, government and industry partners to ensure people who may benefit from Zepbound can access it." Zepbound is expected to be available in the U.S